A new trial of patients with advanced rectal cancer has found that the addition of immunotherapy treatment alongside extended radiotherapy led to better rates of remission. The findings from the ...

Rectal cancer is a type of bowel cancer that develops in the last several centimeters of the large intestine, just before the anus. It’s one of the most common cancers in Europe, with over ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of ...

Kelly Spill didn’t cry when she was diagnosed with stage III rectal cancer at age 28. She held her emotions together when her surgeon told her that she might not be able to carry another baby ...

28,29 In conclusion, we suggest that early response assessment in neoadjuvant rectal cancer trials, on the basis of pCR, TRG, and NAR, may be pragmatically used in early phase II testing to identify ...

First-in-human study of ABBV-400, a novel c-Met–targeting antibody-drug conjugate, in advanced solid tumors: Results in colorectal cancer. Updated results from ERAS-007 plus encorafenib and cetuximab ...

It has recently emerged as a predictor of outcome after surgery for rectal cancer. Our aim was to evaluate if pre-operative serum albumin would predict survival after resection for rectal cancer.

The Phase I trial — meaning it is the first in humans and had the goal of showing the therapy is safe — examined 12 patients with gastrointestinal cancers, including colon and rectal cancer.